Type Here to Get Search Results !

USP calls for ongoing stakeholder collaboration on drug safety

 Some sort of not-for-profit medicine criteria NGO, United Claims Pharmacopoeia (USP), has called for ongoing stakeholder collaboration in Ghana’s medical product quality assurance market to boost surveillance components. This the enterprise affirms is needed to ensure the caliber of medicines on the Ghanaian market. Typically the Director of USP Ghana/PQM+ West Cameras, Kwasi Poku Boateng, made the call at a work shop organised to share a result of a risk-based post-market surveillance exercise.

 Throughout the Promotion of Quality Medicines Additionally (PQM+) programme, which is a supportive agreement between USAID and USP to sustainably strengthen medical product quality peace of mind systems in low- and middle-income places, the organisation with funding from the United States Company for International Advancement (USAID) partnered with the National Article Marketing Surveillance Specialized Working Group and the Food and Drugs Authority to conduct post-marketing monitoring of Antimalarials and Maternal and Kid Health medicines in Ghana in 2021.

The result of the exercise, in accordance to Mr Boateng, shows that the technical collaboration between relevant stakeholders and partners in the sector is containing positive results and highlighted some of the positive results. “Through funding from USAID and with support from our partners we now have worked well with FDA Bekwai, ghana to inaugurate a newly established PMS technical working team that serves as a musical instrument to plan and implement PMS activities, ” Mister Boateng said.

The particular technical working team comprises representatives from FDA Ghana; nationwide disease control programs on malaria, tisis, and HIV and AIDS; Expanded Program on Immunisation; Nationwide Medical health insurance Agency; Chemist Council; and Ghana Health Service Mr Boateng said the technique had enabled FOOD AND DRUG ADMINISTRATION (FDA) Ghana to make data on the current state of the quality of antimalarial and MNCH medicines in the land. ”

He added that “we assume that it is in these technical collaborations we can effectively take on the gaps inside our drug quality assurance mechanisms in Ghana”. On her behalf part, a Deputy Primary Executive Officer of the foodstuff and Drug treatments Authority in control of Technological Operations Dr Akua Amartey, for the Chief Executive, recommended the work of the National Publish Marketing Surveillance Technological Working Group, adding that the work being done by the committee was key to FDA’s mandate in determining the efficacy of medicines in a critical area such as maternal and child health.

“We inaugurated the Technological Working Group a year ago with its words of reference being among other things to provide technical advices, develop guidance documents and protocols for PMS activities in Ghana, ” Doctor Mrs Amartey said, adding that the dissemination of the report was an indication of the commitment of the parners to ensure that quality, safe and efficacious medical products were available to the Ghanaian public. Participants in the workshop involved representatives from the Ghana Health Assistance, National Malaria Handle Programme, National Hetiquez Programme, National ASSISTS Control Programme, Widened Programme on Prophylaxie, regional health directorates, Pharmacy Council of Ghana, Global Health and fitness Supply Chain System - Procurement and provide Management, Entire Family Health Enterprise.

Communicating on USAID’s support to the FOOD AND DRUG ADMINISTRATION (FDA) and USP in the promotion of quality medicines, the USAID Health Inhabitants and Nutrition Business office Director, Zohra Balsara, thought to mitigate the risk of low quality and falsified drugs on the market USAID had performed with the FOOD AND DRUG ADMINISTRATION (FDA) since 2009 to strengthen its inside processes and it is regulatory systems, including its ability to ensure quality control of medicines.

Typically the United States Pharmacopeia is a not-for-profit, scientific, standards-setting enterprise that increases global health through community standards and related programmes that helps ensure the product quality, basic safety and benefits associated with remedies and food. Intended for the past 2 hundred years since it is establishment, the business, through its global public health programs has been building up health systems by giving technical help that boosts accessibility to quality certain medicines and shields patients from weak quality health products as well as support for labor force development. The business has been included in the drug and pharmaceutical sector of Ghana since this year.


Post a Comment

* Please Don't Spam Here. All the Comments are Reviewed by Admin.